BRWA
ALT icon

B. Riley Wealth Advisors’s Altimmune ALT Stock Holding History

B. Riley Wealth Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,955
Closed -$50.4K – 906
2025
Q4 		$50.4K Sell
13,955
-6,525
-32% -$28.4K ﹤0.01% 972
2025
Q3 		$77.2K Buy
20,480
+2,192
+12% +$8.46K ﹤0.01% 979
2025
Q2 		$70.8K Buy
+18,288
New +$99K ﹤0.01% 978
2024
Q4 		$176K Buy
24,454
+1,000
+4% +$7.64K 0.01% 1052
2024
Q3 		$144K Buy
23,454
+2,687
+13% +$18.2K ﹤0.01% 1179
2024
Q2 		$138K Buy
+20,767
New +$153K ﹤0.01% 1284
2022
Q1 		– Sell
-34,000
Closed -$312K – 1383
2021
Q4 		$312K Sell
34,000
-1,227
-3% -$13K 0.01% 1045
2021
Q3 		$399K Sell
35,227
-19,153
-35% -$233K 0.01% 892
2021
Q2 		$536K Buy
54,380
+20,830
+62% +$285K 0.02% 736
2021
Q1 		$475K Buy
33,550
+900
+3% +$14.6K 0.02% 756
2020
Q4 		$369K Buy
+32,650
New +$385K 0.02% 647

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

B. Riley Wealth Advisors's ALT Position: Q1 2026 in Review

B. Riley Wealth Advisors sold out of Altimmune (ALT) in Q1 2026, closing a stake of 13,955 shares — an estimated $50.4K sold.

B. Riley Wealth Advisors first reported a position in ALT in Q4 2020 and held it in 11 quarters. The position peaked at $536K in Q2 2021. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • B. Riley Wealth Advisors reported no remaining Altimmune position as of Q1 2026 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 13,955 Altimmune shares in Q1 2026, an estimated $50.4K.
  • B. Riley Wealth Advisors first reported a position in Altimmune in Q4 2020 and held it in 11 quarters.
  • B. Riley Wealth Advisors's Altimmune position peaked at $536K in Q2 2021.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.